The global Viral Vector & Plasmid DNA Manufacturing market size is estimated at USD 1.44 billion by 2028.It is anticipated to witness a healthy CAGR of about 16.5%. Development of optimized large-scale production, harvest, and purification strategies play a vital role in achieving compliance with regulatory requirements in context to product purity and traceability and therefore will derive the growth of market.

The report provides details on the Viral Vector & Plasmid DNA Manufacturing industry and key market trends. Market surveys include the historical and forecast market data, demand, application details, pricing trends and company stakes in leading geographic viral vectors and plasmid DNA production. The report divides the market size by volume and price based on application type and region.

Request For Sample Copy @

The global market for Viral Vector & Plasmid DNA Manufacturing  is expected to grow at a pace of production throughout the forecast period due to increased cancer incidence worldwide and an increase in the elderly population vulnerable to the disease. In addition, government-led funding and investment by private companies are expected to increase the market for the viral vector and plasmid DNA production. In addition, the untapped potential of developing countries provides a good opportunity for market participants.

Vendor Landscape Competitive Research

Some of the key industry participants are Lonza, Merck KGaA, Oxford Biomedica, Cobra Biologics Limited, Novasep Inc., Spark Therapeutics, Inc., KANEKA CORPORATION, FinVector Vision Therapies, Brammer Bio, Cell and Gene Therapy Catapult, FUJIFILM Holdings Corporation, uniQure N.V., REGENXBIO Inc. and Massbiologics.

By region, the viral vector and plasmid DNA manufacturing markets are categorized as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. In North America, the availability of viral vector-based products has increased, the prevalence of cancer and non-viral diseases has increased, the product pipeline has become richer, and the technological advances in the region have dominated the global viral vector and plasmid DNA manufacturing markets. Asia-Pacific markets are expected to expand significantly to higher CAGRs over the forecast period due to increased research activity in countries such as China and Japan and the availability of approved gene therapy products based on viral vectors.

Special Price for Early Buyer @ $3000

Market Segment

 Vector Type

• Adenovirus
• Retrovirus
• Plasmid DNA
• AAV
• Lentivirus
• Others

By Workflow

• Upstream Processing
• Vector Amplification & Expansion
• Vector Recovery/Harvesting
• Downstream Processing

By Purification

• Fill-finish
• Application
• Antisense, RNAi, & Molecular Therapy
• Vaccinology

By End-use

• Pharmaceutical and Biopharmaceutical Companies
• Research Institutes
• Disease
• Cancer
• Genetic Disorders
• Infectious Diseases
• Others

Reasons to Purchase Viral Vector & Plasmid DNA Manufacturing Market Report:

The report analyses how stringent emission control norms will drive the global Viral Vector & Plasmid DNA Manufacturing market.

Analyzing various perspectives of the market with the help of Porter’s five forces analysis.

Study on the product type that is expected to dominate the market.

Study on the regions that are expected to witness the fastest growth during the forecast period.

Identify the latest developments, market shares and strategies employed by the major Viral Vector & Plasmid DNA Manufacturing market players.

3 months’ analyst support along with the Market Estimate sheet (in excel).

Inquire Before Buying  @

 Table of Contents:

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Viral Vector & Plasmid DNA Manufacturing Market, By Access

6 Global Viral Vector & Plasmid DNA Manufacturing Market, By Deployment Model

7 Global Viral Vector & Plasmid DNA Manufacturing Market, By Type

8 Global Viral Vector & Plasmid DNA Manufacturing Market, By End User

9 Global Viral Vector & Plasmid DNA Manufacturing Market, By Organization Size

10 Global Viral Vector & Plasmid DNA Manufacturing Market, By Geography

11 Key Developments

12 Companies Profiling

Contact Us:

Mr. A Naidu

RESEARCH FOR MARKETS

Email: alan.naidu@researchformarkets.com